敏芯股份(688286.SH):就歌爾股份起訴一案法院裁定準許原告撤回起訴
格隆匯11月11日丨敏芯股份(688286.SH)公佈,近日,公司收到了山東省壽光市人民法院出具的《民事裁定書》。根據該裁定書,就原告歌爾股份有限公司起訴公司及公司子公司蘇州芯儀微電子科技有限公司、崑山靈科傳感技術有限公司、蘇州德斯倍電子有限公司不正當競爭糾紛一案,法院裁定準許原告撤回起訴。根據山東省壽光市人民法院的裁定,本次訴訟事項不會對公司的日常生產經營產生負面影響,也不會對公司當期及未來的損益產生負面影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.